LEXX — Lexaria Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00
- $43.16m
- $34.28m
- $0.23m
2019 August 31st | C2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.16 | -4.08 | -4.19 | -7.38 | -6.71 |
Depreciation | |||||
Non-Cash Items | 1.01 | 1.55 | 0.021 | 2.75 | 0.543 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.08 | -0.194 | 0.064 | -0.351 | 0.143 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -3.01 | -2.62 | -3.99 | -4.88 | -5.88 |
Capital Expenditures | -0.646 | -0.034 | -0.079 | -0.181 | -0.17 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.123 | 0.007 | 0.273 | — | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -0.769 | -0.027 | 0.194 | -0.181 | -0.17 |
Financing Cash Flow Items | 1 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.33 | 2.65 | 13.4 | -0.045 | 1.59 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.442 | 0.009 | 9.62 | -5.1 | -4.46 |